|
Volumn 34, Issue 1, 1999, Pages 1-8
|
Results from late-breaking clinical trials sessions at ACCIS'99 and ACC'99
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARDIOVASCULAR AGENT;
CLOPIDOGREL;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
LANOTEPLASE;
LEFRADAFIBAN;
LOW MOLECULAR WEIGHT HEPARIN;
METOPROLOL;
PLACEBO;
RECOMBINANT VASCULOTROPIN;
CARDIOGENIC SHOCK;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
CORONARY STENT;
HEART FAILURE;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REVIEW;
SURGICAL APPROACH;
TRANSLUMINAL CORONARY ANGIOPLASTY;
|
EID: 0032741068
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(99)00201-6 Document Type: Note |
Times cited : (13)
|
References (0)
|